For instance, CCL26 overexpression correlates with poor prognosis in lung, liver, renal, and urothelial cancers, while in stomach, pancreatic, and endometrial cancers, higher levels are associated with longer overall survival. The gene discussed is CCL26; the disease is endometrial cancer.